![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessProtocol of trans-Tasman feasibility randomised controlled trial of the Younger Women’s Wellness After Breast Cancer (YWWACP) lifestyle intervention
Younger women (defined as those < 50 years who are likely pre-menopausal at time of diagnosis) with breast cancer often experience persistent treatment-related side effects that adversely affect their physical...
-
Article
Open AccessEffect of As-Cast Structure and Macrosegregation on Mechanical Properties in Direct-Quenched Low-Alloy Ultrahigh-Strength Steel
The effect of as-cast structure and macrosegregation on the mechanical properties of a direct-quenched low-alloy martensitic ultrahigh-strength aluminum killed and calcium treated steel cast at different super...
-
Article
Open AccessCorrection to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
The original article contains several small errors. The errors & concurrent corrections are listed below [1]:
-
Article
Impact of age, physiological status and APACHE score on acceptance of patients to the ICU
-
Article
Open AccessPW03-032 – Periodic fevers in children
-
Article
Erratum: Smac mimetics: implications for enhancement of targeted therapies in leukemia
Correction to: Leukemia (2010) 25, 2100–2109; doi:10.1038/leu.2010.212 Owing to a typesetting error, the following sentence was incorrectly printed in the abstract section of the article: ‘The novel inhibitor ...
-
Article
HIN-1, an inhibitor of cell growth, invasion, and AKT1 activation
-
Article
Open AccessPhenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports
Interactions between phenytoin and the fluoropyrimidine derivatives, 5 fluorouracil (5FU) and capecitabine, are not commonly documented or widely recognised. As more people with significant medical comorbiditi...